PT2293816E - Métodos para o tratamento da artrite reumatoide - Google Patents

Métodos para o tratamento da artrite reumatoide

Info

Publication number
PT2293816E
PT2293816E PT97595284T PT09759528T PT2293816E PT 2293816 E PT2293816 E PT 2293816E PT 97595284 T PT97595284 T PT 97595284T PT 09759528 T PT09759528 T PT 09759528T PT 2293816 E PT2293816 E PT 2293816E
Authority
PT
Portugal
Prior art keywords
treatment
methods
rheumatoid arthritis
rheumatoid
arthritis
Prior art date
Application number
PT97595284T
Other languages
English (en)
Inventor
Alan M Solinger
Alexander Owyang
Original Assignee
Xoma Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Technology Ltd filed Critical Xoma Technology Ltd
Publication of PT2293816E publication Critical patent/PT2293816E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/245—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT97595284T 2008-06-06 2009-06-05 Métodos para o tratamento da artrite reumatoide PT2293816E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5971108P 2008-06-06 2008-06-06
US9523208P 2008-09-08 2008-09-08

Publications (1)

Publication Number Publication Date
PT2293816E true PT2293816E (pt) 2013-02-13

Family

ID=40983388

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97595284T PT2293816E (pt) 2008-06-06 2009-06-05 Métodos para o tratamento da artrite reumatoide

Country Status (12)

Country Link
US (1) US20110189172A1 (pt)
EP (1) EP2293816B1 (pt)
JP (2) JP5607613B2 (pt)
AU (1) AU2009256072B2 (pt)
CA (1) CA2727171A1 (pt)
CY (1) CY1113640T1 (pt)
DK (1) DK2293816T3 (pt)
ES (1) ES2398693T3 (pt)
HR (1) HRP20130042T1 (pt)
PL (1) PL2293816T3 (pt)
PT (1) PT2293816E (pt)
WO (1) WO2009149370A1 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8034014B2 (en) 2007-03-06 2011-10-11 Biomet Biologics, Llc Angiogenesis initation and growth
US20080269762A1 (en) * 2007-04-25 2008-10-30 Biomet Manufacturing Corp. Method and device for repair of cartilage defects
AU2008343085B2 (en) 2007-12-20 2015-03-12 Xoma (Us) Llc Methods for the treatment of gout
EP2259774B1 (en) 2008-02-27 2012-12-12 Biomet Biologics, LLC Methods and compositions for delivering interleukin-1 receptor antagonist
US8753690B2 (en) 2008-02-27 2014-06-17 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
US20110052561A1 (en) * 2009-08-27 2011-03-03 Biomet Biologics,LLC Osteolysis treatment
CA2772084C (en) 2009-08-27 2016-10-18 Biomet Biologics, Llc Implantable device for production of interleukin-1 receptor antagonist
EP2977054A1 (en) 2010-09-03 2016-01-27 Biomet Biologics, LLC Methods and compositions for delivering interleukin-1 receptor antagonist
RU2013115927A (ru) * 2010-09-10 2014-10-20 Апексиджен, Инк. АНТИТЕЛА ПРОТИВ ИЛ-1β И СПОСОБЫ ПРИМЕНЕНИЯ
US9011846B2 (en) 2011-05-02 2015-04-21 Biomet Biologics, Llc Thrombin isolated from blood and blood fractions
JP6216765B2 (ja) * 2012-03-19 2017-10-18 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 動脈瘤の治療または予防に使用するための方法および薬学的組成物
KR102345999B1 (ko) 2012-11-05 2021-12-30 델레넥스 쎄라퓨틱스 아게 Il-1 베타 결합성분
WO2014095808A1 (en) 2012-12-17 2014-06-26 Delenex Therapeutics Ag Antibodies against il-1 beta
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9758806B2 (en) 2013-03-15 2017-09-12 Biomet Biologics, Llc Acellular compositions for treating inflammatory disorders
US9878011B2 (en) 2013-03-15 2018-01-30 Biomet Biologics, Llc Treatment of inflammatory respiratory disease using biological solutions
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9833474B2 (en) 2013-11-26 2017-12-05 Biomet Biologies, LLC Methods of mediating macrophage phenotypes
CA2963175A1 (en) 2014-11-10 2016-05-19 F. Hoffmann-La Roche Ag Bispecific antibodies and methods of use in ophthalmology
US10441635B2 (en) 2014-11-10 2019-10-15 Biomet Biologics, Llc Methods of treating pain using protein solutions
CN107001456A (zh) 2014-11-10 2017-08-01 豪夫迈·罗氏有限公司 抗ang2 抗体及使用方法
US9763800B2 (en) 2015-03-18 2017-09-19 Biomet C. V. Implant configured for hammertoe and small bone fixation
WO2021190553A1 (zh) * 2020-03-27 2021-09-30 中山康方生物医药有限公司 抗IL-1β的抗体、其药物组合物及其用途
CN115281149A (zh) * 2021-05-12 2022-11-04 四川大学华西医院 一种临床前类风湿关节炎(Pre-RA)小鼠模型

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077219A (en) * 1984-05-18 1991-12-31 New England Medical Center Hospitals Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins
EP0569687B1 (en) * 1984-05-18 2002-08-21 New England Medical Center Hospitals, Inc. Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins
US4762914A (en) * 1984-05-18 1988-08-09 Auron Philip E Truncated protein of interleukin-1
US5484887A (en) * 1984-06-19 1996-01-16 Immunex Corporation Homogeneous interleukin 1
US5122459A (en) * 1984-12-31 1992-06-16 Immunex Corporation Gene encoding biologically active human interleukin 1
US4772685A (en) * 1985-10-02 1988-09-20 Merck & Co., Inc. Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies
US4935343A (en) * 1986-08-08 1990-06-19 Syntex (U.S.A.) Inc. Monoclonal antibodies for interleukin-1β
US5474899A (en) * 1987-05-13 1995-12-12 Cistron Biotechnology, Inc. Selective immunoassay for IL-1 β
DE68925935T2 (de) * 1988-10-01 1996-08-14 Otsuka Pharma Co Ltd Antikörper gegen Interleukin-1-beta
ES2113856T3 (es) * 1989-02-27 1998-05-16 New England Medical Center Inc Inhibidores de actividad biologica de il-1.
IE922437A1 (en) * 1991-07-25 1993-01-27 Idec Pharma Corp Recombinant antibodies for human therapy
ES2227512T3 (es) * 1991-12-02 2005-04-01 Medical Research Council Produccion de anticuerpos contra auto-antigenos a partir de repertorios de segmentos de anticuerpos fijados en un fago.
US5869619A (en) * 1991-12-13 1999-02-09 Xoma Corporation Modified antibody variable domains
ATE249840T1 (de) * 1991-12-13 2003-10-15 Xoma Corp Verfahren und materialien zur herstellung von modifizierten variablen antikörperdomänen und ihre therapeutische verwendung
WO1994000470A1 (en) * 1992-06-30 1994-01-06 The Wistar Institute Of Anatomy And Biology DEVELOPMENTAL EMBRYONIC MOUSE cDNA LIBRARIES
US5959085A (en) * 1993-11-23 1999-09-28 Schering Corporation Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
US5817476A (en) * 1995-06-07 1998-10-06 Genetics Institute, Inc. Polynucleotides encoding interleukin-1 receptor intracellular ligand proteins
GB0001448D0 (en) * 2000-01-21 2000-03-08 Novartis Ag Organic compounds
EP1712239A3 (en) * 2000-05-12 2007-08-22 Immunex Corporation Interleukin-1 inhibitors in the treatment of diseases
GB0020685D0 (en) * 2000-08-22 2000-10-11 Novartis Ag Organic compounds
US20030026806A1 (en) * 2000-10-27 2003-02-06 Amgen Inc. Antibodies and other selective IL-1 binding agents that allow binding to IL-1 receptor but not activation thereof
US20030166069A1 (en) * 2000-11-28 2003-09-04 Amgen, Inc. Interleukin-1 receptor antagonist-like molecules and uses thereof
US6727234B2 (en) * 2001-04-03 2004-04-27 University Of Iowa Research Foundation Isoprenoid analog compounds and methods of making and use thereof
US20050075488A1 (en) * 2001-07-26 2005-04-07 Bright Stuart Willis Interleukin-1 beta antibodies
US20050152850A1 (en) * 2004-01-09 2005-07-14 Engebretson Steven P. Methods and compositions for facilitating metabolic control
US7732478B2 (en) * 2004-01-09 2010-06-08 The Trustees Of Columbia University In The City Of New York Methods for facilitating metabolic control
US8618054B2 (en) * 2004-05-05 2013-12-31 Valorisation-Rechereche Société en Commandite Interleukin-1 receptor antagonists, compositions, and methods of treatment
SI2163562T1 (sl) * 2005-06-21 2014-01-31 Xoma (Us) Llc IL-1 beta vezavna protitelesa in njihovi fragmenti
SI1940465T1 (sl) * 2005-10-26 2012-10-30 Novartis Ag Nova uporaba protiteles proti IL-1 beta
EP2094306A2 (en) * 2006-12-20 2009-09-02 XOMA Technology Ltd. Treatment of il-1-beta related diseases
AU2008343085B2 (en) * 2007-12-20 2015-03-12 Xoma (Us) Llc Methods for the treatment of gout

Also Published As

Publication number Publication date
JP2015007098A (ja) 2015-01-15
HRP20130042T1 (hr) 2013-03-31
WO2009149370A1 (en) 2009-12-10
JP5809338B2 (ja) 2015-11-10
EP2293816A1 (en) 2011-03-16
JP2011522832A (ja) 2011-08-04
EP2293816B1 (en) 2012-11-07
JP5607613B2 (ja) 2014-10-15
AU2009256072B2 (en) 2015-05-28
ES2398693T3 (es) 2013-03-21
PL2293816T3 (pl) 2013-04-30
AU2009256072A1 (en) 2009-12-10
CA2727171A1 (en) 2009-12-10
DK2293816T3 (da) 2013-02-04
US20110189172A1 (en) 2011-08-04
CY1113640T1 (el) 2016-06-22

Similar Documents

Publication Publication Date Title
PT2293816E (pt) Métodos para o tratamento da artrite reumatoide
HK1208237A1 (en) Methods for the treatment of gout
GB201014633D0 (en) Rheumatoid arthritis treatment
IL232001A0 (en) Preparations for the treatment of rheumatoid arthritis and methods of using them
PL2349957T3 (pl) Proces wytwarzania hydrofluoroolefin
IL227641A0 (en) Methods for treating arthritis
ZA201101932B (en) Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment
EP2352515A4 (en) METHOD FOR TREATING HEMOPHILIA
HUE051430T2 (hu) Eljárás variábilis domének elõállítására
HK1249427A1 (zh) 關節炎治療
AP2011005536A0 (en) Treatment of rheumatoid arthritis with mammal betadefensins.
IL207911A0 (en) Method for the purification of biological macromolecules
IL243809A0 (en) Process for the production of γ-ketosulfide compound and γ-ketosulfide compounds
EP2164515A4 (en) PROCESS FOR TREATING ATOPIC ECZEMA
IL208611A0 (en) Device and process for the formation of microdepositions
EP2164494A4 (en) Methods of Treatment
HK1175072A1 (en) 2-aminoindole compounds and methods for the treatment of malaria 2-
PL2326551T3 (pl) Urządzenie do uzdatniania ścieków
SI2293816T1 (sl) Postopki za zdravljenje revmatoidnega artritisa
IL286709A (en) Compositions for the treatment of rheumatoid arthritis and methods of using same
PL2214846T3 (pl) Urządzenie do obróbki pojemników
AU2009900937A0 (en) Method for treating rheumatoid arthritis
GB0809319D0 (en) The treatment of puritus
SI2527371T1 (sl) Metoda za zdravljenje glomerulonefritisa
GB0823461D0 (en) Treatment of dementia